Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +41.75%
#2 0G 0G +29.50%
#3 SAFEcoin SAFEcoin +27.44%
#4 Seeker Seeker +23.54%
#5 Pons Pons +21.03%
#6 Zora Zora +20.06%
#7 VVS Finance VVS Finance +18.18%
#8 Full Moon Full Moon +17.70%
#9 Axelar Axelar +17.50%
#10 Concordium Concordium +17.01%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Impact Therap-b Impact Therap-b

Impact Therap-b

7630
Kedudukan dalam Saham #13207
IMPACT Therapeutics, a biotechnology firm, specializes in the discovery and... IMPACT Therapeutics, a biotechnology firm, specializes in the discovery and advancement of precision anti-cancer treatments rooted in synthetic lethality, operating across China and international markets. The company's primary offering, Senaparib (IMP4297), is a PARP1/2 inhibitor currently deployed as a first-line maintenance therapy for ovarian cancer. Beyond this, Impact Therapeutics maintains a robust pipeline of investigational drugs. This includes IMP1734, a next-generation PARP1 selective inhibitor undergoing Phase I/II trials as a standalone treatment for advanced solid tumors. Another promising candidate is IMP9064, an ATR kinase selective inhibitor, also in Phase I/II clinical studies for advanced solid tumors as a monotherapy. IMP1707, a PARP1 selective inhibitor capable of penetrating the central nervous system, is in Phase I development for homologous recombination repair-deficient tumors. Additionally, IMP7068, an advanced WEE1 inhibitor, is progressing through Phase I/II clinical trials for various advanced solid tumors. Furthermore, a range of other compounds, namely IMP22, IMP25, IMP08, IMP13, IMP10, IMP27, and IMP32, are in the preclinical development phase. The company, established in 2009, is headquartered in Shanghai, China.
Harga Saham
$1.85
Modal Pasaran
$510.85M
Perubahan (1 hari)
-7.37%
Perubahan (1 tahun)
-
Negara
CN
Perdagangan Impact Therap-b (7630)

Kategori

Healthcare
Sejarah dividen untuk Impact Therap-b (7630)
Impact Therap-b (simbol saham: 7630) telah membuat sejumlah 0 pembayaran dividen.
Jumlah semua dividen (disesuaikan untuk pemecahan saham): 0.00
Hasil dividen (TTM): 0
Pembayaran dividen untuk Impact Therap-b (7630) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (diselaraskan untuk pemecahan saham) Ubah
Tidak cukup data untuk tarikh yang disediakan.
Senarai semua pembayaran dividen
Tahun Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pembayaran dividen untuk syarikat serupa atau pesaing
Syarikat Jumlah pembayaran dividen Negara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
215.00%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
225.00%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
53.00%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
33.00%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
223.00%
US